Human beta-defensins (HBD1 and HBD3) and malignant melanoma susceptibility.
Fernandez LP, Milne RL, Pita G, Floristan U, Sendagorta E, Feito M, Aviles JA, Martin-Gonzalez M, Lázaro P, Benítez J, Ribas G.
Fernandez LP, et al. Among authors: floristan u.
Melanoma Res. 2009 Oct;19(5):340-1. doi: 10.1097/CMR.0b013e328330106a.
Melanoma Res. 2009.
PMID: 19741426
No abstract available.